Scoopfeeds — Intelligent news, curated.
A New Vaccine Was Designed by AI and Safey Tested on Humans
health

A New Vaccine Was Designed by AI and Safey Tested on Humans

Healthline · Jun 11, 2026, 9:39 PM

Why this matters: health reporting relevant to everyday decisions and well-being.

A new vaccine designed by AI is the first to be tested on humans and may protect against a wide range of coronaviruses related to SARS and COVID-19. miodrag ignjatovic/Getty Images Researchers have tested a vaccine designed to protect against a range of coronaviruses. This new vaccine was the first designed by AI to be tested on humans. The p EVAC-PS vaccine could enable protection against future mutations. The use of AI also enables the development of new vaccines much faster. However, more research is needed to determine whether it works in a more diverse population. According to an article found in the June 2026 issue of the Journal of Infection, researchers have safely tested a new vaccine designed to protect against a wide range of coronaviruses related to SARS and COVID-19. As a press release from the University of Cambridge explains, this trial is the first time that a vaccine whose active component was designed entirely by computer simulations has been tested in humans. This vaccine, developed by a team of scientists from the University of Southampton, the University of Cambridge, and DIOSynVax Ltd., is called pEVAC-PS. The technology uses a “super-antigen” designed by artificial intelligence (AI) to create protection against a wide range of viruses, even when mutations occur. Current methods for developing vaccines lack this ability, making frequent reformulations necessary to keep up with ever-changing viruses. While the vaccine was found to be safe and without significant side effects, the authors say a larger trial is needed to determine whether it can provide strong protection in a more diverse population. AI-designed vaccine tested on humans for the first time In the study, it was given to healthy volunteers in the U.K. between December 2021 and September 2023. The goal was to create a vaccine that could defend not only against current COVID-19 variants but also against future coronavirus threats that might potentially jump from animals to hu

Article preview — originally published by Healthline. Full story at the source.
Read full story on Healthline → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Healthline alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop